August 14, 2023
VIA EDGAR SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance, Office of Life Sciences
100 F Street, NE
Washington, DC 20549
Attention: Dillon Hagius
| Re: | Trevi Therapeutics, Inc. |
Registration Statement on Form S-3 |
File No. 333-273030 |
Request for Acceleration |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Trevi Therapeutics, Inc. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-273030), so that it may become effective at 4:00 p.m., Eastern Time, on August 15, 2023, or as soon as practicable thereafter.
Very truly yours, | ||
TREVI THERAPEUTICS, INC. | ||
| By: | /s/ Jennifer L. Good | |
Name: Jennifer L. Good | ||
Title: Chief Executive Officer | ||
